Central conventional chondrosarcomas carry mutations in IDH1 or IDH2 in 38–70% of primary central chondrosarcomas (arising without a preexisting benign enchondroma) and in 86% of the secondary central chondrosarcomas [4–6]. Here, IDH2 is linked to chondrosarcoma.